Research ArticleNeurology
Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging
Alex Whittington and Roger N. Gunn; for the Alzheimer’s Disease Neuroimaging Initiative
Journal of Nuclear Medicine April 2019, 60 (4) 536-540; DOI: https://doi.org/10.2967/jnumed.118.210518
Alex Whittington
1Division of Brain Sciences, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom
2Invicro Ltd., London, United Kingdom; and
Roger N. Gunn
1Division of Brain Sciences, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom
2Invicro Ltd., London, United Kingdom; and
3Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 4
April 1, 2019
Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging
Alex Whittington, Roger N. Gunn
Journal of Nuclear Medicine Apr 2019, 60 (4) 536-540; DOI: 10.2967/jnumed.118.210518
Jump to section
Related Articles
Cited By...
- Amyloid age and tau PET timeline to symptomatic Alzheimers disease in Down syndrome
- Label-free and reference region-free X-ray cross-{beta} index for quantifying protein aggregates of neurodegenerative diseases
- Direct Comparison of the Tau PET Tracers 18F-Flortaucipir and 18F-MK-6240 in Human Subjects
- Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimers Disease
- TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
- Widespread cell stress and mitochondrial dysfunction in early Alzheimers Disease